Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION, USP
| Report ID | 230033 |
| Drug Identification Number | 02491699 |
| Brand name | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 mL |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-06-12 |
| Actual start date | |
| Estimated end date | 2024-07-19 |
| Actual end date | 2024-07-11 |
| Shortage status | Resolved |
| Updated date | 2024-07-19 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our HYDROmorphone Hydrochloride Injection, USP 2 mg/mL SD Vial 1 mL effective June 12, 2024 until July 19, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-07-19 | French | Compare |
| v4 | 2024-07-19 | English | Compare |
| v3 | 2024-06-13 | English | Compare |
| v2 | 2024-06-10 | French | Compare |
| v1 | 2024-06-10 | English | Compare |
Showing 1 to 5 of 5